瘤坏死因子作为慢性B细胞恶性瘤的自身隐性瘤生长因子
F T Cordingley1, A Bianchi, A V Hoffbrand
1Department of Haematology, Royal Free Hospital, London.
Lancet (London, England)
|April 30, 1988
概括
再组合瘤缩因子 (TNF) 促进毛细胞白血病和B型慢性淋巴细胞白血病细胞的存活和增殖. 干扰素α,但不干扰素gamma,对抗这些促进生长的效果.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 瘤亡因子 (TNF) 是一种关键的细胞因子,参与免疫反应和炎症.
- 像毛细胞白血病 (HCL) 和B慢性淋巴细胞白血病 (B-CLL) 这样的B细胞恶性瘤的特征是淋巴细胞的不受控制的增殖.
- 作为这些白血病的潜在生长因子,TNF的作用需要进一步研究.
研究的目的:
- 研究复合TNF对HCL和B-CLL细胞的存活和增殖的影响.
- 为了确定TNF是否可以在这些恶性瘤中充当自身隐性生长因子.
- 检查干扰素 (IFN) 对TNF诱导的白血病细胞生长的潜在对抗作用.
主要方法:
- 来自HCL和B-CLL患者的白血病细胞培养.
- 用复合瘤亡因子 (TNF) 治疗.
- 对细胞存活,增殖和TNF mRNA和蛋白质表达的分析.
- 与阿尔法干扰素 (IFN-α) 和玛干扰素 (IFN-γ) 的共同培养实验.
主要成果:
- 再组合TNF显著促进了HCL和B-CLL瘤细胞的存活率和诱导的增殖.
- 治疗TNF导致TNFmRNA和蛋白质的表达增加,表明自身隐性活性.
- 干扰素-α (IFN-α) 有效地对抗了TNF的促进生长的作用.
- 干扰素- (IFN-γ) 对TNF诱导的增殖没有任何对抗作用.
结论:
- 瘤坏死因子 (TNF) 作为毛细胞白血病和B型慢性淋巴细胞白血病细胞的强有力的生长因子.
- 在这些B细胞恶性瘤中,TNF可能起到自身隐性生长因子的作用.
- 干扰素-α (IFN-α) 是一种潜在的治疗剂,可以抵消TNF驱动的白血病细胞生长,而IFN-γ则没有.
更多相关视频
19:44Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
Published on: May 30, 2012
06:36A Modified In vitro Invasion Assay to Determine the Potential Role of Hormones, Cytokines and/or Growth Factors in Mediating Cancer Cell Invasion
Published on: April 24, 2015
相关概念视频
Autocrine Signaling
Autocrine signaling is one of the many signaling mechanisms that function inside multicellular organisms to carry out intercellular communication. In this type of signaling mechanism, the same cell that secretes an extracellular signaling molecule also expresses the receptors to bind and respond to that signaling molecule.
Autocrine Signaling in Macrophages
Under normal physiological conditions, autocrine signaling is essential for maintaining homeostasis. This process is well characterized in...
Autocrine Signaling in Macrophages
Under normal physiological conditions, autocrine signaling is essential for maintaining homeostasis. This process is well characterized in...
Mitogens and the Cell Cycle
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
Receptor Downregulation in MVBs
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
TGF - β Signaling Pathway
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
